|
Aug 4
|
Pharma CEOs downplay impact of tariffs amid rising cost concerns
|
|
Aug 4
|
J&J Expects Better Top-Line Growth in 2H: Can It Achieve the Goal?
|
|
Aug 4
|
How Did Skyrizi and Rinvoq Sales Contribute to AbbVie's Q2 Results?
|
|
Aug 3
|
Why Drug Prices for Some Big Medicines Will Remain High for a Longer Time
|
|
Aug 3
|
If You'd Invested $1,000 in AbbVie (ABBV) Stock 10 Years Ago, Here's How Much You'd Have Today
|
|
Aug 2
|
3 Unstoppable Stocks to Buy in August
|
|
Aug 2
|
3 Dividend Champion Stocks I'm Watching in 2025
|
|
Aug 1
|
Why AbbVie Stock Flew Higher on Friday
|
|
Aug 1
|
AbbVie (ABBV) Reports Increased Sales But Lower Net Income For Q2 2025
|
|
Aug 1
|
AbbVie Soars On Skyrizi And Rinvoq Strength, Outpacing Humira Erosion
|
|
Aug 1
|
Why AbbVie (ABBV) Stock Is Up Today
|
|
Aug 1
|
3 Dividend Healthcare Stocks to Buy Hand Over Fist Before They Double
|
|
Aug 1
|
Fibromyalgia Market Analysis Report 2025-2035 | Key Players Drive Competition in Expanding Treatment Options
|
|
Aug 1
|
Tenosynovitis Market Research Report 2025-2035 | Rising Demand for Tenosynovitis Treatment Amid Increasing Rheumatoid Arthritis Cases
|
|
Aug 1
|
AbbVie Inc (ABBV) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Raised Guidance ...
|
|
Aug 1
|
Trump doubles down on Most Favored Nation plan to target drug prices
|
|
Jul 31
|
Why AbbVie Stock Slumped Today
|
|
Jul 31
|
Trump Talks Tough on Drug Prices but His Demands Have Softened
|
|
Jul 31
|
What Trump's Big Pharma CEO letters mean for drug pricing power
|
|
Jul 31
|
Sector Update: Health Care Stocks Fall Late Afternoon
|